Khiron Life Sciences Corp. (TSXV:KHRN), (OTCQB: KHRNF) Director Vincente Fox joined the Midas Letter to touch on the progress made over a decade of cannabis advocacy, specifically in Mexico. Fox served as the 55th President of Mexico between December 2000 and November 2006, beginning a path towards medical cannabis legalization. According to Fox, the current Mexican government is very liberal in its stance towards cannabis and is expected to introduce further medical cannabis regulations in four to eight weeks. Fox expects recreational cannabis regulations in Mexico to be introduced within the next year.

While the presence of drug cartels in Mexico has created cause for concern over cannabis legalization, the legalization process in Mexico is expected to be similar to that in Colombia. According to Fox, the cartels operating in the area have already diversified their operations to the point that they can afford to lose their profits from cannabis production without major consequences.


“Those that participated in the old illegal industry, at the very end they join in and become legal. Now they are businessmen and salesmen, owners of small stores. That is the process. The new legal industry dominates over the old criminal industry,” said Fox.

To watch the full interview, click here.

Click here to connect with Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQB: KHRNF) for an Investor Presentation.

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less